China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the stock. China Pharma Price Performance China Pharma stock opened at $0.09 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.82 and […]
More Stories
Musk’s SpaceX Acquires xAI to ‘Accelerate Humanity’s Future’
By Troy Myers Two of entrepreneur Elon Musk’s most pioneering companies, SpaceX and xAI, merged Monday with a combined goal...
Groundhog Day 2026: Punxsutawney Phil Spots His Shadow, and You Know What That Means
By Elma Aksalic Punxsutawney Phil, the Pennsylvania groundhog and central figure to the Feb. 2 tradition, delivered a disappointing weather...
Trump Launches $12 Billion ‘Project Vault’ Critical Minerals Stockpile
By Catherine Yang President Donald Trump announced on Feb. 2 a new strategic private sector critical minerals stockpile. “Project Vault”...
Gabbard Defends Presence at Fulton County Election Warrant Execution
By Zachary Stieber National Intelligence Director Tulsi Gabbard on Feb. 2 defended her presence at a Fulton County elections office...
CDC Warns Vaccinated People Can Still Get Measles
By Zachary Stieber The Centers for Disease Control and Prevention is warning people that even those who have received a...
Trump Says Republicans Should ‘Take Over’ and Nationalize Voting in Some Areas
By Aldgra Fredly President Donald Trump said in a podcast interview with former FBI deputy director Dan Bongino on Feb....